U.S. Crackdown on Chinese Biotech Could Harm Patients by Lilu Anderson 22.06.2024 America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Hang Seng Index Surges Amid China Market Rebound Hopes by Mark Eisenberg 16.02.2024 Hong Kong's Hang Seng index surged 2.4% as traders bet on China-exposed stocks ahead of mainland market reopening. Real estate ...